Pain (Professional) (cont.)
IN THIS ARTICLE
Changes to This Summary (02/28/2013)
The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.
Added text about a study that evaluated episodic (breakthrough) pain in patients with chronic cancer-related pain (cited Caraceni et al. as reference 22).
Added text to state that patients taking nonsteroidal anti-inflammatory drugs (NSAIDs) are at risk for platelet dysfunction that may impair blood clotting; Table 1 lists NSAIDs with minimal antiplatelet activity.
Added acetaminophen (rectal) to the Parenteral Medications section of Table 1. Editorial changes were also made throughout the table.
Added text about a study of nabiximols for patients with advanced cancer who had opioid-refractory pain (cited Portenoy et al. as reference 273).
This summary is written and maintained by the PDQ Supportive and Palliative Care Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ NCI's Comprehensive Cancer Database pages.
Questions or Comments About This Summary
If you have questions or comments about this summary, please send them to Cancer.gov through the Web site's Contact Form. We can respond only to email messages written in English.
eMedicineHealth Public Information from the National Cancer Institute
This information is produced and provided by the National Cancer Institute (NCI). The information in this topic may have changed since it was written. For the most current information, contact the National Cancer Institute via the Internet web site at http://cancer.gov or call 1-800-4-CANCER
This information is not intended to replace the advice of a doctor. Healthwise disclaims any liability for the decisions you make based on this information.
Some material in CancerNet™ is from copyrighted publications of the respective copyright claimants. Users of CancerNet™ are referred to the publication data appearing in the bibliographic citations, as well as to the copyright notices appearing in the original publication, all of which are hereby incorporated by reference.